Taiwan Liposome Company, Ltd.

Home » Taiwan Liposome Company, Ltd.

IPO

Taiwan Liposome Company, Ltd.

They are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).

Symbol

TLC

Price Range
$7.46 - $7.46

Final Shares
4,700,000

Anticipated Date
TBD

Underwriters
Cantor, CLSA, H.C. Wainwright & Co., Janney Montgomery Scott, Laidlaw & Company (UK) Ltd.

To view the prospectus for Taiwan Liposome Company, Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253